| Product Code: ETC8285743 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Parkinsons Disease Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Parkinsons Disease Market - Industry Life Cycle |
3.4 Mexico Parkinsons Disease Market - Porter's Five Forces |
3.5 Mexico Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Mexico Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Mexico Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Mexico Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Mexico Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Mexico Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Mexico |
4.2.2 Growing awareness and diagnosis rates of Parkinson's disease |
4.2.3 Advancements in treatment options and therapies for Parkinson's disease |
4.3 Market Restraints |
4.3.1 High cost of Parkinson's disease medications and treatments |
4.3.2 Limited access to specialized healthcare facilities in some regions of Mexico |
4.3.3 Lack of trained healthcare professionals in managing Parkinson's disease patients |
5 Mexico Parkinsons Disease Market Trends |
6 Mexico Parkinsons Disease Market, By Types |
6.1 Mexico Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mexico Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Mexico Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Mexico Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Mexico Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Mexico Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Mexico Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Mexico Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Mexico Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Mexico Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Mexico Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Mexico Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Mexico Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Mexico Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Mexico Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Mexico Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Mexico Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mexico Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Mexico Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Mexico Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Mexico Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Mexico Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Mexico Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mexico Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Mexico Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Mexico Parkinsons Disease Market Export to Major Countries |
7.2 Mexico Parkinsons Disease Market Imports from Major Countries |
8 Mexico Parkinsons Disease Market Key Performance Indicators |
8.1 Number of new Parkinson's disease cases diagnosed annually in Mexico |
8.2 Adoption rate of new Parkinson's disease treatments in the market |
8.3 Patient satisfaction with Parkinson's disease management services provided |
8.4 Number of clinical trials and research studies focused on Parkinson's disease in Mexico |
8.5 Percentage of Parkinson's disease patients receiving regular follow-up care and support |
9 Mexico Parkinsons Disease Market - Opportunity Assessment |
9.1 Mexico Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Mexico Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Mexico Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Mexico Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Mexico Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Mexico Parkinsons Disease Market - Competitive Landscape |
10.1 Mexico Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Mexico Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here